Mark Ayoub

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 13

Top Topics

Atrial Fibrillation

Oral Anticoagulants

Cardiovascular Events

Top Venues

JGH open : an open access journal of gastroenterology and hepatology

Diseases (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mark Ayoub, Carol Faris, Julton Tomanguillo Chumbe, Ebubekir Daglilar, Nadeem Anwar, Vishnu Naravadi
Safety of DOACs in patients with Child-Pugh Class C cirrhosis and atrial fibrillation. JGH open : an open access journal of gastroenterology and hepatology 8 (5) (2024)
Mark Ayoub, Carol Faris, Julton Tomanguillo Chumbe, Ebubekir Daglilar, Nadeem Anwar, Vishnu Naravadi
Safety of DOACs in patients with Child-Pugh Class C cirrhosis and trial fibrillation. JGH open : an open access journal of gastroenterology and hepatology 8 (5) (2024)
Mark Ayoub, Carol Faris, Julton Tomanguillo Chumbe, Ebubekir Daglilar, Nadeem Anwar, Vishnu Naravadi
Safety of DOACs in patients with Child-Pugh Class C cirrhosis and atrial fibrillation. JGH open : an open access journal of gastroenterology and hepatology 8 (5) (2024)
Mark Ayoub, Julton Tomanguillo, Carol Faris, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar
Use of proton pump inhibitors improves outcomes in mild acute pancreatitis: A nationwide cohort study. Medicine 103 (14) (2024)
Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglilar
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 16 (9) (2024)
Mark Ayoub, Julton Tomanguillo, Carol Faris, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar
Use of proton pump inhibitors improves outcomes in mild acute pancreatitis: A nationwide cohort study. Medicine 103 (14) (2024)
Mark Ayoub, Carol Faris, Tajana Juranovic, Rafi Aibani, Morgan Koontz, Harleen Chela, Nadeem Anwar, Ebubekir Daglilar
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database. Diseases (Basel, Switzerland) 12 (7) (2024)
Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglilar
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 16 (9) (2024)
Mark Ayoub, Carol Faris, Julton Tomanguillo, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar
The Use of Pre-Endoscopic Metoclopramide Does Not Prevent the Need for Repeat Endoscopy: A U.S. Based Retrospective Cohort Study. Life (Basel, Switzerland) 14 (4) (2024)
Mark Ayoub, Carol Faris, Julton Tomanguillo Chumbe, Ebubekir Daglilar, Nadeem Anwar, Vishnu Naravadi
Safety of DOACs in patients with Child-Pugh Class C cirrhosis and trial fibrillation. JGH open : an open access journal of gastroenterology and hepatology 8 (5) (2024)
Mark Ayoub, Carol Faris, Tajana Juranovic, Rafi Aibani, Morgan Koontz, Harleen Chela, Nadeem Anwar, Ebubekir Daglilar
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database. Diseases (Basel, Switzerland) 12 (7) (2024)
Mark Ayoub, Carol Faris, Julton Tomanguillo, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar
The Use of Pre-Endoscopic Metoclopramide Does Not Prevent the Need for Repeat Endoscopy: A U.S. Based Retrospective Cohort Study. Life (Basel, Switzerland) 14 (4) (2024)
Mark Ayoub, Carol Faris, Tajana Juranovic, Rafi Aibani, Morgan Koontz, Harleen Chela, Nadeem Anwar, Ebubekir Daglilar
Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database. Diseases (Basel, Switzerland) 12 (7) (2024)